AbbVie (4AB) Stock Statistics & Valuation Metrics
Total Valuation
AbbVie has a market cap or net worth of EUR 461.75B. The enterprise value is EUR 533.71B.
- Market Cap
- EUR 461.75B
- Enterprise Value
- EUR 533.71B
Share Statistics
AbbVie has 1,767,616,300 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 1,767,616,300
- Owned by Insiders
- 0.06%
- Owned by Institutions
- 50.07%
Financial Efficiency
AbbVie’s return on equity (ROE) is -1.29 and return on invested capital (ROIC) is 12.97%.
- Return on Equity (ROE)
- -1.29
- Return on Assets (ROA)
- 0.03
- Return on Invested Capital (ROIC)
- 12.97%
- Return on Capital Employed (ROCE)
- 0.22
- Revenue Per Employee
- 1.07M
- Profits Per Employee
- 74.14K
- Employee Count
- 57,000
- Asset Turnover
- 0.46
- Inventory Turnover
- 3.68
Valuation Ratios
The current PE Ratio of AbbVie is 49.97. AbbVie’s PEG ratio is 0.15.
- PE Ratio
- 49.97
- PS Ratio
- 7.80
- PB Ratio
- -112.63
- Price to FCF
- 27.28
- Price to Operating Cash Flow
- 25.70
- PEG Ratio
- 0.15
Income Statement
In the last 12 months, AbbVie had revenue of 61.16B and earned 4.23B in profits. Earnings per share was 2.37.
- Revenue
- 61.16B
- Gross Profit
- 42.96B
- Operating Income
- 20.09B
- Pretax Income
- 6.60B
- Net Income
- 4.23B
- EBITDA
- 17.63B
- Earnings Per Share (EPS)
- 2.37
Cash Flow
In the last 12 months, operating cash flow was 20.09B and capital expenditures -1.22B, giving a free cash flow of 18.87B billion.
- Operating Cash Flow
- 20.09B
- Free Cash Flow
- 18.87B
- Free Cash Flow per Share
- 10.65
Dividends & Yields
AbbVie pays an annual dividend of EUR 1.52, resulting in a dividend yield of 2.31%
- Dividend Per Share
- EUR 1.52
- Dividend Yield
- 2.31%
- Payout Ratio
- 65.64%
- Free Cash Flow Yield
- 3.67%
- Earnings Yield
- 2.01%
Stock Price Statistics
- Beta
- 0.25
- 52-Week Price Change
- 37.70%
- 50-Day Moving Average
- 238.66
- 200-Day Moving Average
- 205.32
- Relative Strength Index (RSI)
- 59.61
- Average Volume (3m)
- 594
Important Dates
AbbVie upcoming earnings date is Feb 03, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Oct 30, 2026
- Next Earnings Date
- Feb 03, 2027
- Ex-Dividend Date
- Jul 15, 2026
Financial Position
AbbVie as a current ratio of 0.67, with Debt / Equity ratio of -2112.17%
- Current Ratio
- 0.67
- Quick Ratio
- 0.56
- Debt to Market Cap
- 0.17
- Net Debt to EBITDA
- 3.62
- Interest Coverage Ratio
- 6.94
Taxes
In the past 12 months, AbbVie has paid 2.36B in taxes.
- Income Tax
- 2.36B
- Effective Tax Rate
- 0.36
Enterprise Valuation
AbbVie EV to EBITDA ratio is 24.22, with an EV/FCF ratio of 30.99.
- EV to Sales
- 8.86
- EV to EBITDA
- 24.22
- EV to Free Cash Flow
- 30.99
- EV to Operating Cash Flow
- 29.12
Balance Sheet
AbbVie has EUR 10.77B in cash and marketable securities with EUR 80.90B in debt, giving a net cash position of -EUR 70.13B billion.
- Cash & Marketable Securities
- EUR 10.77B
- Total Debt
- EUR 80.90B
- Net Cash
- -EUR 70.13B
- Net Cash Per Share
- -EUR 39.67
- Tangible Book Value Per Share
- -EUR 55.86
Margins
Gross margin is 76.25%, with operating margin of 35.53%, and net profit margin of 15.68%.
- Gross Margin
- 76.25%
- Operating Margin
- 35.53%
- Pretax Margin
- 19.41%
- Net Profit Margin
- 15.68%
- EBITDA Margin
- 36.58%
- EBIT Margin
- 27.79%
Analyst Forecast
The average price target for AbbVie is EUR 275.05, which is 11.43% higher than the current price. The consensus rating is Strong Buy
- Price Target
- EUR 275.05
- Price Target Upside
- 5.91% Upside
- Analyst Consensus
- Strong Buy
- Analyst Count
- 24
- Revenue Growth Forecast
- 5.37%
- EPS Growth Forecast
- 312.68%
Scores
- Smart Score
- 6
- AI Score
- ―
